A groundbreaking study shows findings that show a treatment can shrink tumors and improve survival outcomes for patients with ...

All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

In a phase 1 trial, all 9 patients with renal cell carcinoma treated with a neoantigen-targeting personalized cancer vaccine ...

A highly vascularized cancer that is especially reliant on tumor endothelial cells is clear cell renal cell carcinoma (ccRCC). Almost 80% of malignant tumors in the kidney are ccRCC ... She found that ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

This is a two-day course on renal pathology for Specialist Registrars and Consultants in Renal Medicine to be held on 30-31 January 2025. The course is specifically designed for nephrologists to teach ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening ... clinics and now in renal clinics, so I would hope the ...

Hypocalcemia may result from deficient calcium intake, vitamin D deficiency, steatorrhea, acute pancreatitis, renal disease ... of the kidney at autopsy were within normal limits.

The symptoms of acute renal failure occur because these substances accumulate in the body when the kidney does not work the way it should. Normal fluid and electrolyte levels are necessary for the ...

Clear cell renal cell carcinoma (ccRCC ... antiprogrammed cell PD-1 IgG4k antibody that has been approved in China for the treatment of kidney carcinoma. The utilization of ICIs has shown significant ...